Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;30(1):17-24.
doi: 10.1097/MOP.0000000000000570.

Precision medicine in pediatric oncology

Suzanne J Forrest  1 , Birgit Geoerger  2   3 , Katherine A Janeway  1
Affiliations
Review

Precision medicine in pediatric oncology

Suzanne J Forrest et al. Curr Opin Pediatr. 2018 Feb.

Abstract

Purpose of review: The current review describes recent advances and unique challenges in precision medicine for pediatric cancers and highlights clinical trials assessing the clinical impact of targeted therapy matched to molecular alterations identified by tumor profiling.

Recent findings: Multiple prospective clinical sequencing studies in pediatric oncology have been reported in the last 2 years. These studies demonstrated feasibility of sequencing in the clinic and revealed a rate of actionable variants that justifies the development of precision trials for childhood cancer. A number of precision medicine trials are recently completed, underway or in development and these will be reviewed herein, with a focus on highlighting aspects of precision medicine trial design relevant to pediatric oncology.

Summary: The primary results of the first round of pediatric precision oncology clinical trials will provide us with a greater understanding of the clinical impact of linking tumor profiling to selection of targeted therapies. The aggregation of sequencing and clinical data from these trials and the results of biologic investigations linked to these trials will drive further discoveries and broaden opportunities for precision medicine for children with cancer.

PubMed Disclaimer

Figures

Box 1
Box 1
no caption available
See this image and copyright information in PMC

Similar articles

  • Pediatric oncology enters an era of precision medicine.
    Seibel NL, Janeway K, Allen CE, Chi SN, Cho YJ, Glade Bender JL, Kim A, Laetsch TW, Irwin MS, Takebe N, Tricoli JV, Parsons DW. Seibel NL, et al. Curr Probl Cancer. 2017 May-Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1. Curr Probl Cancer. 2017. PMID: 28343740
  • Precision Medicine in Pediatric Oncology.
    Vo KT, Parsons DW, Seibel NL. Vo KT, et al. Surg Oncol Clin N Am. 2020 Jan;29(1):63-72. doi: 10.1016/j.soc.2019.08.005. Epub 2019 Oct 29. Surg Oncol Clin N Am. 2020. PMID: 31757314 Free PMC article. Review.
  • Precision cancer medicine: the future is now, only better.
    Tsimberidou AM, Eggermont AM, Schilsky RL. Tsimberidou AM, et al. Am Soc Clin Oncol Educ Book. 2014:61-9. doi: 10.14694/EdBook_AM.2014.34.61. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857061 Review.
  • Ushering in the next generation of precision trials for pediatric cancer.
    DuBois SG, Corson LB, Stegmaier K, Janeway KA. DuBois SG, et al. Science. 2019 Mar 15;363(6432):1175-1181. doi: 10.1126/science.aaw4153. Science. 2019. PMID: 30872517 Review.
  • Targeted therapy in cancer.
    Tsimberidou AM. Tsimberidou AM. Cancer Chemother Pharmacol. 2015 Dec;76(6):1113-32. doi: 10.1007/s00280-015-2861-1. Epub 2015 Sep 21. Cancer Chemother Pharmacol. 2015. PMID: 26391154 Free PMC article. Review.
See all similar articles

Cited by

  • How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
    Cipri S, Abenavoli L, Boccuto L, Del Baldo G, Mastronuzzi A. Cipri S, et al. Medicina (Kaunas). 2022 Oct 2;58(10):1386. doi: 10.3390/medicina58101386. Medicina (Kaunas). 2022. PMID: 36295546 Free PMC article. Review.
  • A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
    Cohen JW, Akshintala S, Kane E, Gnanapragasam H, Widemann BC, Steinberg SM, Shah NN. Cohen JW, et al. Oncologist. 2020 Jun;25(6):532-540. doi: 10.1634/theoncologist.2019-0615. Epub 2020 Jan 14. Oncologist. 2020. PMID: 31943534 Free PMC article.
  • The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets.
    van Tilburg CM, Pfaff E, Pajtler KW, Langenberg KPS, Fiesel P, Jones BC, Balasubramanian GP, Stark S, Johann PD, Blattner-Johnson M, Schramm K, Dikow N, Hirsch S, Sutter C, Grund K, von Stackelberg A, Kulozik AE, Lissat A, Borkhardt A, Meisel R, Reinhardt D, Klusmann JH, Fleischhack G, Tippelt S, von Schweinitz D, Schmid I, Kramm CM, von Bueren AO, Calaminus G, Vorwerk P, Graf N, Westermann F, Fischer M, Eggert A, Burkhardt B, Wößmann W, Nathrath M, Hecker-Nolting S, Frühwald MC, Schneider DT, Brecht IB, Ketteler P, Fulda S, Koscielniak E, Meister MT, Scheer M, Hettmer S, Schwab M, Tremmel R, Øra I, Hutter C, Gerber NU, Lohi O, Kazanowska B, Kattamis A, Filippidou M, Goemans B, Zwaan CM, Milde T, Jäger N, Wolf S, Reuss D, Sahm F, von Deimling A, Dirksen U, Freitag A, Witt R, Lichter P, Kopp-Schneider A, Jones DTW, Molenaar JJ, Capper D, Pfister SM, Witt O. van Tilburg CM, et al. Cancer Discov. 2021 Nov;11(11):2764-2779. doi: 10.1158/2159-8290.CD-21-0094. Epub 2021 Aug 9. Cancer Discov. 2021. PMID: 34373263 Free PMC article.
  • How to Design Peptides.
    Dodd-O J, Acevedo-Jake AM, Azizogli AR, Mulligan VK, Kumar VA. Dodd-O J, et al. Methods Mol Biol. 2023;2597:187-216. doi: 10.1007/978-1-0716-2835-5_15. Methods Mol Biol. 2023. PMID: 36374423 Free PMC article.
  • Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia.
    Haeusler GM, Phillips R, Slavin MA, Babl FE, De Abreu Lourenco R, Mechinaud F, Thursky KA; Australian PICNICC study group and the PREDICT network. Haeusler GM, et al. EClinicalMedicine. 2020 Jun 15;23:100394. doi: 10.1016/j.eclinm.2020.100394. eCollection 2020 Jun. EClinicalMedicine. 2020. PMID: 32637894 Free PMC article.
See all "Cited by" articles

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2016; 66:7–30. - PubMed
    1. Armstrong GT, Chen Y, Yasui Y, et al. Reduction in late mortality among 5-year survivors of childhood cancer. N Engl J Med 2016; 374:833–842. - PMC - PubMed
    1. National Cancer Institute childhood cancer genomics gaps and opportunities: identification of research priorities workshop summary. 2015:1–33.
    1. Loh ML, Zhang J, Harvey RC, et al. Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood 2013; 121:485–488. - PMC - PubMed
    1. Gadd S, Huff V, Walz AL, et al. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor. Nat Genet 2017; 49:1487–1494. - PMC - PubMed